Nucleos(t)ide Analogues
Treatment of HBeAg Negative Chronic Hepatitis B Patients with Nucleos(t)ide Analogues in Burkina Faso
... The treatment of chronic hepatitis B (CHB) has increased significantly in re- cent years. In patients affected by HBeAg-negative CHB, it is necessary to dis- tinguish the inactive carriers (low viral DNA < 2000 IU/mL, ...
10
Long term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg negative
... of liver disease. CHB may present either as hepatitis B e antigen (HBeAg)-positive or HBeAg-negative. The pre- valence of HBeAg-negative CHB has been increasing over the last decade and represents the majority of cases ...
7
Long Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long Term Complications: a meta analysis
... Methods: We searched MEDLINE, EMBASE, OVID, the Cochrane Central Register of Controlled Trials. Relative risks (RRs) of long-term complications with or without treatment were studied. Also subgroup analyses including the ...
11
Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy
... that nucleos(t) ide analogues (NAs) are highly effective in the suppression circulating viral loads, but rarely eliminate the virus over the last ten years ...
10
Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation
... Because of the high rate of HBV reactivation-related morbidity and mortality in such individuals, there has been an increase in the awareness of the importance of prophylactic anti-HBV treatment during chemotherapy. ...
17
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
... used nucleos(t)ide analogues in developing countries because they are much less expensive than novel analogues such as entecavir and tenofovir disoproxil fumarate, yet they show ...
11
Effect of 48 week pegylated interferon α 2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B
... interferon-α (IFN-α) or nucleos(t)ide analogues (NUCs). Five NUCs are currently available, including two nucleo- tide (adefovir [ADV] and tenofovir [TDF]) and three nucleoside (lamivudine ...
8
Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practice
... Table 2 compares those other studies that do analyze the response to treatment, as ALT normalization and viral load undetectability, according to HBV genotype. Among the few available studies, it stands out one conducted ...
10
Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study
... with nucleos(t)ide analog (NUC) treatment for chronic hepatitis B ...B, nucleos(t)ide analogues, adherence, follow-up, ...
5
<p>Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues</p>
... Background and Aims: Potential drug resistance (DR) related variants in the hepatitis B virus (HBV) reverse transcriptase (RT) region may be associated with the effectiveness of antivira[r] ...
10
Elevated expression of serum soluble ST2 in clinical relapse after stopping long term Nucleos(t)ide analogue therapy for chronic hepatitis B
... It had been suggested that a relapse, resulting in in- creased HBV replication, could change the cytokine milieu and lead to increased responsiveness of HBV-specific T cells and NK cells at 12 weeks after stopping ...
9
Pre-existing mutations related to tenofovir in chronic hepatitis B patients with long-term nucleos(t)ide analogue drugs treatment by ultra-deep pyrosequencing
... Results: At baseline, all 46 treatment-naïve patients harbored rtA181V/T substitutions (1.2%-4.6%) and rtN236T substitutions (1.6%-6.1%). In the ADV group, eight patients with long-term treatment were ...
12
Off treatment virologic relapse and outcomes of re treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
... The univariate and multivariate logistic regression ana- lyses showed that duration of NA therapy is an inde- pendent predictor of off-treatment sustained virologic remission in CHB. This finding is in line with previous ...
8
Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
... available nucleos(t)ide monotherapies used to treat Chinese CHB ...five nucleos(t)ide monotherapies (LAM, ADV, TBV, ETV, and TDF) currently used for CHB ...
14
Deployment of NS-3 with Eclipse IDE
... Abstract: Network Simulators is typically used to study services and applications in complex scenarios due to the infeasibility of deploying real testbeds. Many problems can be solved by using network simulators such as ...
19
Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
... ABSTRACT The study was designed to investigate whether serum hepatitis B vi- rus (HBV) RNA is a strong surrogate marker for intrahepatic HBV covalently closed circular DNA (cccDNA) compared with serum HBV DNA, hepatitis ...
11
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study
... Methods: Prospective, multicentre study in which efficacy, safety and pharmacokinetics of a regimen of once-daily SQVr 1500/100 mg plus 2 NRTIs were evaluated under routine clinical care[r] ...
9
Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional study
... Combined ARV regimens did not significantly influence the incidence of NRTI and NNRTI associated mutations. The duration of ARV therapy and the child's age had no significant impact on the ARV related mutations. The ...
7
Fear vs Hope: Do Discrete Emotions Mediate Message Frame Effectiveness In Genetic Cancer Screening Appeals
... 45. Brodney, M. A.; Barreiro, G.; Oglivie, K.; Hajos-Korcsok, E.; Murray, J.; Vajdos, F.; Ambroise, C.; Christoffersen, C.; Fisher, K.; Lanyon, L.; Liu, J.; Nolan, C. E.; Withka, J. M.; Borzilleri, K. A.; Efremov, I.; ...
125
PERFUSION PUMP: MATHEMATICAL MODELING USING BOND GRAPH FOR BLOOD PRESSURE CONTROL
... The theory based on Bond Graph technique consists in an approach to energy that defines two generalized power state variables (input variables effort e(t) and flow f(t)) in order to identify the equivalent ...
7